Eli Lilly Doubles Down On Vaccines Portfolio; Makes Three Key Acquisitions For Nearly $4 Billion

Eli Lily will undertake the acquisition of Curevo, Limmatech and Vaccine Co, in order to consolidate its vaccine and infectious disease treatment portfolio.